These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: a case report and review of the current literature. Pott C, Dechering DG, Reinke F, Muszynski A, Zellerhoff S, Bittner A, Köbe J, Wasmer K, Schulze-Bahr E, Mönnig G, Kotthoff S, Eckardt L. Europace; 2011 Jun; 13(6):897-901. PubMed ID: 21292648 [Abstract] [Full Text] [Related]
15. Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia. Jiang D, Jones PP, Davis DR, Gow R, Green MS, Birnie DH, Chen SR, Gollob MH. Channels (Austin); 2010 Jun; 4(4):302-10. PubMed ID: 20676041 [Abstract] [Full Text] [Related]
16. Sudden death after inappropriate shocks of implantable cardioverter defibrillator in a catecholaminergic polymorphic ventricular tachycardia case with a novel RyR2 mutation. Itoh H, Murayama T, Kurebayashi N, Ohno S, Kobayashi T, Fujii Y, Watanabe M, Ogawa H, Anzai T, Horie M. J Electrocardiol; 2021 Jun; 69():111-118. PubMed ID: 34656916 [Abstract] [Full Text] [Related]
17. Advances in the diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Roston TM, Cunningham TC, Sanatani S. Cardiol Young; 2017 Jan; 27(S1):S49-S56. PubMed ID: 28084961 [Abstract] [Full Text] [Related]
18. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A. Circulation; 2002 Jul 02; 106(1):69-74. PubMed ID: 12093772 [Abstract] [Full Text] [Related]